Skip to content

Clinical trials

Approved for marketing Expanded access trials in the United Kingdom

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Phase: Expanded access Status: Approved for marketing Country / region: United Kingdom Clear all

12 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20061

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Approved for marketing12

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Eli Lilly and Company3
Gilead Sciences2
Pfizer2
AstraZeneca1
BioMarin Pharmaceutical1
Boehringer Ingelheim1
Janssen Research & Development, LLC1
Novartis1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Breast Neoplasms2
Bites and Stings1
COVID-191
Carcinoma, Non-Small-Cell Lung1
Carcinoma, Renal Cell1
Dermatomyositis1
Fever1
Gastrointestinal Neoplasms1
HIV Infections1
Head and Neck Neoplasms1

Trials

Showing 1 to 12 of 12. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.